NO20045579L - Behandling av hepatitt C i den asiatiske populasjonen med subkutan interferon beta - Google Patents

Behandling av hepatitt C i den asiatiske populasjonen med subkutan interferon beta

Info

Publication number
NO20045579L
NO20045579L NO20045579A NO20045579A NO20045579L NO 20045579 L NO20045579 L NO 20045579L NO 20045579 A NO20045579 A NO 20045579A NO 20045579 A NO20045579 A NO 20045579A NO 20045579 L NO20045579 L NO 20045579L
Authority
NO
Norway
Prior art keywords
treatment
hepatitis
interferon beta
asian population
subcutaneous interferon
Prior art date
Application number
NO20045579A
Other languages
English (en)
Inventor
Lan Parsons
Theodor Wee Tit Gin
Birgit J Maschek
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20045579L publication Critical patent/NO20045579L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Anvendelsen av rekombinant IFN-( for produksjon av et medikament for behandling av HCV-infeksjon ved subkutan administrering til pasienter av asiatisk rase som ikke har respondert på en tidligere behandling med interferon-(, er rapportert her. Ifølge en foretrukken utførelse av oppfinnelsen kan denne behandlingen være bedre og ytterligere fokusert på de pasienter som etter fire ukers begynnende 10 behandling med IFN-(, viser HCV RNA-fjeming.
NO20045579A 2002-06-03 2004-12-21 Behandling av hepatitt C i den asiatiske populasjonen med subkutan interferon beta NO20045579L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02100632 2002-06-03
PCT/EP2003/050202 WO2003101478A1 (en) 2002-06-03 2003-05-28 Treatment of hepatitis c in the asian population with subcutaneous interferonbeta

Publications (1)

Publication Number Publication Date
NO20045579L true NO20045579L (no) 2005-01-26

Family

ID=29595047

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045579A NO20045579L (no) 2002-06-03 2004-12-21 Behandling av hepatitt C i den asiatiske populasjonen med subkutan interferon beta

Country Status (21)

Country Link
US (1) US7344709B2 (no)
EP (1) EP1509242A1 (no)
JP (1) JP2005533035A (no)
KR (1) KR20050008762A (no)
CN (1) CN1671408A (no)
AR (1) AR039915A1 (no)
AU (1) AU2003250231B2 (no)
BR (1) BR0311696A (no)
CA (1) CA2487299A1 (no)
EA (1) EA007091B1 (no)
HR (1) HRP20041076A2 (no)
IL (1) IL165521A (no)
MX (1) MXPA04012043A (no)
MY (1) MY139068A (no)
NO (1) NO20045579L (no)
PL (1) PL374578A1 (no)
RS (1) RS105104A (no)
TW (1) TWI334785B (no)
UA (1) UA79615C2 (no)
WO (1) WO2003101478A1 (no)
ZA (1) ZA200409218B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200633718A (en) * 2004-12-16 2006-10-01 Applied Research Systems Treatment of hepatitis c in the asian population
WO2009069682A1 (ja) * 2007-11-28 2009-06-04 Toray Industries, Inc. 肝炎の治療剤又は予防剤
US20100316608A1 (en) * 2009-06-15 2010-12-16 Vijayaprakash Suppiah Method of Determining A Response To Treatment With Immunomodulatory Composition
WO2013059638A1 (en) 2011-10-21 2013-04-25 Abbvie Inc. Combination treatment (eg. with abt-072 or abt -333) of daas for use in treating hcv
CN103826627B (zh) 2011-10-21 2016-02-24 艾伯维公司 包含至少两种直接抗病毒剂和利巴韦林的组合物在制备治疗hcv的药物中的用途
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
CN102538594B (zh) * 2012-01-10 2013-12-25 西安工业大学 交汇式激光精度靶及其测试方法
JP7129703B2 (ja) 2016-04-28 2022-09-02 エモリー ユニバーシティー アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4737462A (en) * 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US5116943A (en) * 1985-01-18 1992-05-26 Cetus Corporation Oxidation-resistant muteins of Il-2 and other protein
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
US4965195A (en) * 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
DK1421956T3 (da) 1998-04-28 2007-10-01 Applied Research Systems Polyol-IFN-beta-konjugater

Also Published As

Publication number Publication date
TW200407159A (en) 2004-05-16
IL165521A0 (en) 2006-01-15
EP1509242A1 (en) 2005-03-02
IL165521A (en) 2010-05-17
KR20050008762A (ko) 2005-01-21
EA200401618A1 (ru) 2005-06-30
ZA200409218B (en) 2006-02-22
WO2003101478A1 (en) 2003-12-11
AU2003250231A1 (en) 2003-12-19
CN1671408A (zh) 2005-09-21
TWI334785B (en) 2010-12-21
US7344709B2 (en) 2008-03-18
AU2003250231B2 (en) 2009-01-08
BR0311696A (pt) 2005-03-22
AR039915A1 (es) 2005-03-09
PL374578A1 (en) 2005-10-31
UA79615C2 (en) 2007-07-10
CA2487299A1 (en) 2003-12-11
MY139068A (en) 2009-08-28
HRP20041076A2 (en) 2005-02-28
JP2005533035A (ja) 2005-11-04
MXPA04012043A (es) 2005-03-07
EA007091B1 (ru) 2006-06-30
RS105104A (en) 2007-02-05
US20060029572A1 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
ATE475423T1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen
ATE473750T1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der unterdrückung von hepatitis virus infektion
DK0662157T3 (da) Præparater og fremgangsmåde til behandling af Hepatitis C-virus-associerede sygdomme
NO20073632L (no) Behandling av hepatitt C med interferon-beta i en asiatisk populasjon
NO20100093L (no) Peptidomimetiske protease-inhibitorer
NO20045579L (no) Behandling av hepatitt C i den asiatiske populasjonen med subkutan interferon beta
ATE476983T1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen der atemwege
NO20052136L (no) Vaksine mot Hepatitt C-virus (HCV).
ATE508738T1 (de) System zur beabstandeten abgabe von arzneimitteln
ATE373679T1 (de) Antimikrobiell wirksames oder endotoxin neutralisierendes polypeptid
GT200300244A (es) Isomeros posicionales del ifn peg alfa 2a
MX2021002147A (es) Tratamiento de la infección por virus de la hepatitis delta con interferón lambda.
DE60237721D1 (de) Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen
MXPA03000061A (es) Manipulacion de virus de arn encadenados negativos mediante redisposicion de sus genes y usos de los mismos.
DK1334119T3 (da) Sammensætninger og fremgangsmåder til modulering af RSV-infektion og -immunitet
NO20055512L (no) Terapi eller prevensjon av respiratoriske, virale infeksjoner med alfa-tyimosinpeptider
ATE482272T1 (de) Zytokinproteinfamilie
HUP0105070A2 (hu) Hepatitis B vírus fertőzések megelőzésére és kezelésére szolgáló készlet
MXPA02005506A (es) Clonacion de un gen que codifica una racemasa de aminoacido derivada de tripanosoma cruzi, y usos del mismo.
HUP0300354A2 (hu) HIV immunadjuváns terápia
HUP0401657A2 (hu) Eljárás hepatitis-C vírusfertőzés kezelésére eredménytelenül kezelt betegek esetében
AR005750A1 (es) Composicion farmaceutica para tratar o prevenir infecciones con zoster en personas infectadas con el virus de varicela zoster y procedimiento para preparar dicha composicion
HUP0401659A2 (hu) Eljárás hepatitis-C vírusfertőzés kezelésére eredménytelenül kezelt betegek esetében
WO2005058237A3 (en) Treatment of aids
ATE204760T1 (de) Verwendung von thymosin zur behandlung von hepatitis c bei patienten, die auf interferongaben nicht ansprechen

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application